{"data":{"id":745,"lang":"en","title":"Single Injection of Engineered Brain Cells Cuts Alzheimer's Plaques by 50% in Mice, Washington University Study Shows","summary":"WashU scientists used CAR-engineered astrocytes to cut Alzheimer's plaques by 50% with a single injection in mice.","category":"science","category_label":"Science","published_at":"2026-03-12T13:01:38Z","updated_at":"2026-03-12T13:01:38Z","url":"https://techtools.cz/tools/news/article/745-single-injection-of-engineered-brain-cells-cuts-alzheimer-s-plaques-by-50-in","api_url":"https://techtools.cz/news-api/v1/articles/745?lang=en","markdown_url":"https://techtools.cz/news-api/v1/articles/745.md?lang=en","image_url":"https://sciencedaily.com/images/1920/enhanced-brain-cells-clear-away-dementia-related-proteins.webp","word_count":165,"reading_time_minutes":1,"sources":[{"url":"https://www.sciencedaily.com/releases/2026/03/260311004720.htm","domain":"sciencedaily.com"},{"url":"https://medicine.wustl.edu/","domain":"medicine.wustl.edu"}],"translation":{"lang":"cs","id":761,"title":"Jediná injekce upravených mozkových buněk snížila Alzheimerovy plaky o 50 % u myší, ukazuje studie Washingtonské univerzity","url":"https://techtools.cz/tools/news/clanek/761-jedina-injekce-upravenych-mozkovych-bunek-snizila-alzheimerovy-plaky-o-50-u","api_url":"https://techtools.cz/news-api/v1/articles/761?lang=cs"},"content":"Scientists at Washington University School of Medicine in St. Louis have engineered astrocytes — abundant brain support cells — with CAR technology to target and clear amyloid beta plaques linked to Alzheimer's disease. A single injection of these modified cells reduced plaque levels by approximately 50% in mice with existing plaques. In younger mice treated before plaque formation, the therapy prevented plaques entirely by six months of age.\n\nThe approach adapts chimeric antigen receptor (CAR) technology, originally developed for cancer treatment, to neurodegenerative disease. Senior author Marco Colonna, MD, noted that current monoclonal antibody therapies give patients roughly 10 additional months of independence but require monthly or twice-monthly infusions. The engineered astrocytes need only a single injection, potentially offering a far more practical treatment path.\n\nThe study, published March 5 in the journal Science, represents the first use of CAR-engineered brain cells against a neurodegenerative condition. While the results are in mice, the researchers say the technique could eventually complement or replace existing antibody treatments for Alzheimer's."}}